arrow
Return

Estimating the public health and economic impact of increased COVID-19 annual vaccination coverage in the 60 years and older population in Spain

delete2026-05-23
delete0
delete
OA
AI
M
Moreno Guillen, Santiago
R
Redondo Marguello, Esther
R
Rodriguez Garcia, Juan
A
Aceituno, Susana
P
Prades, Miriam
J
Jingyan Yang
L
Lopez Rodriguez, Angeles
M
Molina, Carlos
L
Lopez-Ibanez de Aldecoa, Alejandra *
DOI:10.1080/13696998.2026.2643130delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
BackgroundCOVID-19 annual vaccination uptake in Spain remains suboptimal. This study aimed to estimate the clinical and economic impact of the 2023/2024 COVID-19 vaccination campaign in individuals aged >= 60 years (scenario A: coverage of 33.14% for ages 60-69, 53.15% for 70-79, and 65.32% for >= 80), and to compare it with a hypothetical scenario (scenario B) where coverage reaches the 75% target set by the Spanish Ministry of Health.MethodsA combined Markov-decision tree model adapted to the Spanish context simulated the weekly progression of the target population through six health states over one year. Infected individuals entered a decision tree reflecting different care pathways (outpatient, hospital ward, ICU with/without invasive mechanical ventilation [IMV], or death), each associated with specific health outcomes and direct costs (& euro;2024). Clinical and economic outcomes were compared between scenarios A and B. Sensitivity analyses explored incremental increases in coverage and age-specific impacts. The analysis was conducted from the National Healthcare System (NHS) perspective.ResultsUnder scenario A, 378,970 symptomatic infections occurred, leading to 27,611 hospitalizations, 742 ICU admissions (47.3% requiring IMV), and 3,611 deaths. A total of 2,750 quality-adjusted life years (QALYs) were lost, and COVID-19-related care costs reached & euro;240.4 million (85.7% from inpatient care). Scenario B, with 75% coverage, averted -19,409 symptomatic infections, 1,094 hospitalizations, 41 ICU admissions, and 129 deaths, 138 lost QALYs and total cost savings of about & euro;10.5 million. Sensitivity analysis showed how the model is sensitive to sequential increases (10% by 10%) in vaccination rates and highlighted the importance of achieving high vaccination rates, especially in older age groups.ConclusionsThis analysis reveals the significant impact that increasing annual COVID-19 vaccination coverage among the Spanish population over 60 could have in preventing new infections, reducing severe disease consequences, and generating considerable cost savings for the NHS.
Keywords:
COVID-19 vaccines
vaccination coverage
immunization
secondary
quality-adjusted life years
public health
I18
H51

Journal

Journal of Medical Economics cover
Journal of Medical Economics
IF:
3
Papers:
347
Citations:
3.6K

Organization

P
pfizer
Scholars:
660
Papers: 204
Citations: 0
P
pfizer usa
Scholars:
7.2K
Papers: 4.4K
Citations: 3
I
institut investigacio sanitaria illes balears (idisba)
Scholars:
1.4K
Papers: 805
Citations: 1
H
Hospital Universitari Son Espases
Scholars:
3.1K
Papers: 2.0K
Citations: 12
U
universidad de alcala
Scholars:
7.9K
Papers: 6.8K
Citations: 7
H
Hospital Universitario Ramon y Cajal
Scholars:
8.4K
Papers: 5.9K
Citations: 27
researcher View more organizations